EIN Presswire’s Year-End Special is here: Buy 5 press releases & get 3 FREE—limited time! Start saving today.

EIN Presswire’s Year-End Special is here: Buy 5 press releases & get 3 FREE—limited time! Start saving today.

World Media Directory · RSS · Email Newsletters

There were 1,597 press releases posted in the last 24 hours and 358,325 in the last 365 days.

Press Releases on February 27, 2023

1,899 Press Releases

Published on February 27, 2023 - 21:04 GMT

TaskUs Announces Fiscal Fourth Quarter and Full Year 2022 Results

FY 2022 Revenue and Adjusted EBITDA Above Most Recent Outlook Over 26% Revenue Growth in FY 2022 Added 40 Clients in FY 2022 Number of Clients over $1 Million in Revenue Increased by 19% in FY 2022; Number of Clients over $10 Million in Revenue Increased …

Distribution channels: Business & Economy, IT Industry ...
Published on February 27, 2023 - 21:03 GMT

Progyny, Inc. Announces Fourth Quarter 2022 Results

Reports Full Year Revenue of $786.9 Million, Reflecting 57% Growth Reports Record Quarterly Revenue and Operating Cash Flow of $214.3 Million and $51.5 Million, Respectively Issues Financial Guidance for 2023, Anticipates Crossing $1 Billion Revenue …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on February 27, 2023 - 21:01 GMT

TPI Composites Announces Proposed Offering of $100 Million Convertible Senior Notes

SCOTTSDALE, Ariz., Feb. 27, 2023 (GLOBE NEWSWIRE) -- TPI Composites, Inc. (“TPI”) (Nasdaq: TPIC) announced today that it has commenced a private offering of $100.0 million aggregate principal amount of convertible senior notes due 2028 (the “notes”) to …

Distribution channels: Consumer Goods ...
Published on February 27, 2023 - 21:01 GMT

Galapagos presenteert nieuwe data van langetermijn-uitbreidingsstudie van filgotinib bij colitis ulcerosa op jaarlijks ECCO ...

Zes presentaties tonen Galapagos' betrokkenheid bij inflammatoire darmziekten (IBD) Nieuwe analyses van de fase 3 SELECTION en SELECTION langetermijn-uitbreidingsstudies (LTE) van Jyseleca® (filgotinib, een orale, eenmaal daagse, preferentiële JAK1- …

Distribution channels: Media, Advertising & PR, Technology ...
Published on February 27, 2023 - 21:01 GMT

Galapagos to present new data from long-term extension study of filgotinib in ulcerative colitis at annual ECCO congress 2023

Six presentations demonstrate Galapagos’ commitment to the inflammatory bowel disease (IBD) community New analyses from Phase 3 SELECTION and SELECTION long-term extension (LTE) studies of Jyseleca® (filgotinib, an oral, once daily, JAK1 preferential …

Distribution channels: Media, Advertising & PR, Technology ...
Published on February 27, 2023 - 21:01 GMT

argenx Appoints Steve Krognes to Board of Directors

February 27, 2023 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that during the extraordinary general …

Distribution channels: Media, Advertising & PR, Technology ...
Published on February 27, 2023 - 21:01 GMT

Vaxcyte Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

-- Company Received U.S. Food and Drug Administration (FDA) Clearance of VAX-24 Infant Investigational New Drug (IND) Application and Expects to Initiate Phase 2 Study in Second Quarter 2023 -- -- Topline Safety, Tolerability and Immunogenicity Results …

Distribution channels: Business & Economy, Technology ...
Published on February 27, 2023 - 21:01 GMT

Denali Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for the treatment of …

Distribution channels: Business & Economy, Technology ...
Published on February 27, 2023 - 21:01 GMT

EnviroGold Global Provides Corporate Update

TORONTO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold Global” or the “Company”), a Clean Technology Company accelerating the world’s transition to a circular-resource economy, announces that …

Distribution channels: Banking, Finance & Investment Industry
Published on February 27, 2023 - 21:01 GMT

FibroGen Reports Fourth Quarter and Full Year 2022 Financial Results

Topline Data from Five Pivotal Phase 3 Trials in 2023 Total Company Revenue $140.7 Million in 2022 Continued Strong Roxadustat Volume Growth in China SAN FRANCISCO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today reported financial …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on February 27, 2023 - 21:01 GMT

Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results

IRVINE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on February 27, 2023 - 21:01 GMT

Conifer Holdings Schedules Fourth Quarter 2022 Earnings Conference Call/Webcast for March 9, 2023

TROY, Mich., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Conifer Holdings, Inc. (Nasdaq: CNFR) announced today that it will host a conference call/webcast on Thursday, March 9, 2023 at 8:30am Eastern Time to discuss financial results for the fourth quarter ended …

Distribution channels: Culture, Society & Lifestyle, Insurance Industry ...
Published on February 27, 2023 - 21:01 GMT

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on February 28, 2023

HAMILTON, Bermuda, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, February 28, 2023, at 8:30 a.m. Eastern Time to report its fourth quarter and …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 27, 2023 - 21:01 GMT

Travere Therapeutics Announces Proposed Public Offering of Common Stock

SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that it intends to offer and sell, in an underwritten public offering and subject to market and other conditions, $175,000,000 of its common stock. All …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on February 27, 2023 - 21:00 GMT

Arvinas to Participate in Upcoming Investor Conferences

NEW HAVEN, Conn., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in two upcoming …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on February 27, 2023 - 21:00 GMT

Atrion Corporation Declares Quarterly Cash Dividend

ALLEN, Texas, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $2.15 per share on its outstanding shares of Common Stock. This dividend will be payable on March …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on February 27, 2023 - 21:00 GMT

Chinook Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates

SEATTLE, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today reported financial results for …

Distribution channels: Business & Economy, Technology ...
Published on February 27, 2023 - 21:00 GMT

Goldenbridge Acquisition Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business ...

NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Goldenbridge Acquisition Limited (NASDAQ: GBRGU, the “Company”), a special purpose acquisition company, announced today that Auto Services Group Limited (“SunCar”), has deposited into the Company’s trust account …

Distribution channels: Banking, Finance & Investment Industry
Published on February 27, 2023 - 21:00 GMT

Atrion Reports Fourth Quarter and Full Year 2022 Results

ALLEN, Texas, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the fourth quarter ended December 31, 2022 and the full year 2022. Revenues for the fourth quarter of 2022 totaled $42.9 million compared to $ …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on February 27, 2023 - 20:55 GMT

Governor Mills Announces $15 Million in Maine Jobs & Recovery Grant Funding to Expand Career and Technical Education in Maine

Governor Janet Mills today announced that four Career and Technical Education (CTEs) schools in Maine will receive $15 million in grant funding through her Maine Jobs & Recovery plan for program, equipment, and facility upgrades. The grant funding will …

Distribution channels:

Previous 10 11 12 13 14 15 16 17 18 19 20 Next

Previous Day 2023 Calendar Next Day